Literature DB >> 21601579

Acetylcholine chloride as a potential source of variability in the study of cutaneous vascular function in man.

Fabien Sauvet1, Guillaume Mahé, Mounir Chennaoui, Christophe Langrume, Mélanie Vasseur, Pierre Abraham, Georges Leftheriotis.   

Abstract

INTRODUCTION: Laser-Doppler flowmetry (LDF) coupled with acetylcholine chloride (ACh) iontophoresis is increasingly recognized as a reliable non-invasive method to study the endothelial function. However, ACh-vasodilation measurement appears highly variable possibly due to the ACh pharmacological properties itself. These problems may be partially overcome by using methacholine chloride (MCh), a more stable synthetic agonist of muscarinic receptors, instead of ACh. Therefore, we first studied the correlation between the two drugs and then the effects of (1) spatial variability (inter-site measurements), (2) temporal variability (inter-day measurements), (3) intra-day variability (morning versus evening), and (4) age on the variability of both ACh-vasodilation and MCh-vasodilation.
METHODS: The endothelium-dependent vasodilation response to simultaneous iontophoretic applications (4 doses of 10s at 0.1mA with 2min of current-free interval) of ACh (11mM) or MCh (10mM) was studied on the forearm of 40 healthy subjects (36 males, median 28yr, range 21-59yr). The percent change in perfusion (CVCpeak) from baseline and the area under the curve (CVC(AUC)) during iontophoresis were assessed. Inter-site, inter-day and intra-day coefficients of variation (CV) were studied for each drug as well as correlations between drugs and age.
RESULTS: A linear relationship was found between ACh- and MCh-CVCpeak (r²=0.75, p=0.01) and between ACh- and MCh-CVC(AUC) (r²=0.55, p=0.02). MCh inter-site CV for both CVCpeak (12.2%) and CVC(AUC) (13.8%) was significantly lower than ACh inter-site CV for CVCpeak (15.5%) and CVC(AUC) (15.3%), respectively. MCh inter-day CV for CVCpeak (17.2%) and CVC(AUC) (14.6%) was significantly lower than ACh inter-day CV for CVCpeak (19.7%) and ACh CVC(AUC) (21.2%). For ACh and MCh, the CVCpeak and CVC(AUC) were higher at 16:00pm than at 11:00am (p<0.05 for all). Finally, both ACh- and MCh-CVCpeak exhibited a logarithmic decrease with age (r²=0.61, p<0.01 and r²=0.58, p<0.01).
CONCLUSION: Although both drugs exhibited circadian and age variability, MCh exhibited less inter-site and interday variabilities than did ACh for the evaluation of cutaneous endothelium-dependent vasodilation. These findings should be taken into account in studies of cutaneous vascular function by iontophoresis coupled with laser Doppler flowmetry.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21601579     DOI: 10.1016/j.mvr.2011.05.001

Source DB:  PubMed          Journal:  Microvasc Res        ISSN: 0026-2862            Impact factor:   3.514


  4 in total

1.  Cutaneous microvascular functional assessment during exercise: a novel approach using laser speckle contrast imaging.

Authors:  G Mahe; P Abraham; A Le Faucheur; A Bruneau; A Humeau-Heurtier; S Durand
Journal:  Pflugers Arch       Date:  2013-01-18       Impact factor: 3.657

2.  Effects of 29-h total sleep deprivation on local cold tolerance in humans.

Authors:  Fabien Sauvet; C Bourrilhon; Y Besnard; A Alonso; J-M Cottet-Emard; G Savourey; J-C Launay
Journal:  Eur J Appl Physiol       Date:  2012-01-10       Impact factor: 3.078

3.  Endothelial-derived hyperpolarization contributes to acetylcholine-mediated vasodilation in human skin in a dose-dependent manner.

Authors:  Vienna E Brunt; Naoto Fujii; Christopher T Minson
Journal:  J Appl Physiol (1985)       Date:  2015-09-17

4.  Reproducibility of non-invasive assessment of skin endothelial function using laser Doppler flowmetry and laser speckle contrast imaging.

Authors:  Cyril Puissant; Pierre Abraham; Sylvain Durand; Anne Humeau-Heurtier; Sébastien Faure; Georges Lefthériotis; Pascal Rousseau; Guillaume Mahé
Journal:  PLoS One       Date:  2013-04-19       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.